Phenotype
|
Fish
|
Conditions
|
Figures
|
whole organism nfkb2 expression increased amount, abnormal
|
tlx1cq201/cq201
|
bacterial treatment by exposure to environment: Aeromonas hydrophila
|
Figure 1
from Xie et al., 2021
|
liver tnfb expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
gut left side tlx1 expression absent, abnormal
|
tlx1cq201/cq201
|
standard conditions
|
Fig. 3
from Xie et al., 2019
|
whole organism decreased life span, exacerbated
|
tlx1cq201/cq201
|
bacterial treatment by injection: Aeromonas hydrophila
|
Fig. 5
from Xie et al., 2019
|
whole organism nfkb2 expression increased amount, abnormal
|
tlx1cq201/cq201
|
chemical treatment by environment: lipopolysaccharide
|
Figure 1
from Xie et al., 2021
|
intestine nfkb2 expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
intestine tnfa expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
kidney ighm expression decreased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 9
from Xie et al., 2021
|
spleen absent, abnormal
|
tlx1cq201/cq201
|
standard conditions
|
Fig. 4
from Xie et al., 2019
|
whole organism il1b expression increased amount, abnormal
|
tlx1cq201/cq201
|
chemical treatment by environment: lipopolysaccharide
|
Figure 1
from Xie et al., 2021
|
trunk apoptotic process increased occurrence, abnormal
|
tlx1cq201/cq201
|
chemical treatment by environment: lipopolysaccharide
|
Figure 1
from Xie et al., 2021
|
whole organism tnfa expression increased amount, abnormal
|
tlx1cq201/cq201
|
bacterial treatment by exposure to environment: Aeromonas hydrophila
|
Figure 1
from Xie et al., 2021
|
intestine tnfb expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
whole organism il6 expression increased amount, abnormal
|
tlx1cq201/cq201
|
bacterial treatment by exposure to environment: Aeromonas hydrophila
|
Figure 1
from Xie et al., 2021
|
whole organism tnfb expression increased amount, abnormal
|
tlx1cq201/cq201
|
bacterial treatment by exposure to environment: Aeromonas hydrophila
|
Figure 1
from Xie et al., 2021
|
trunk apoptotic process increased occurrence, abnormal
|
tlx1cq201/cq201
|
bacterial treatment by exposure to environment: Aeromonas hydrophila
|
Figure 1
from Xie et al., 2021
|
liver tnfa expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
liver il6 expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
kidney mhc2dhb expression decreased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 9
from Xie et al., 2021
|
liver il10 expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
liver il1b expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
immune response decreased process quality, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 9
from Xie et al., 2021
|
whole organism il10 expression increased amount, abnormal
|
tlx1cq201/cq201
|
bacterial treatment by exposure to environment: Aeromonas hydrophila
|
Figure 1
from Xie et al., 2021
|
whole organism tnfb expression increased amount, abnormal
|
tlx1cq201/cq201
|
chemical treatment by environment: lipopolysaccharide
|
Figure 1
from Xie et al., 2021
|
whole organism il10 expression increased amount, abnormal
|
tlx1cq201/cq201
|
chemical treatment by environment: lipopolysaccharide
|
Figure 1
from Xie et al., 2021
|
intestine il10 expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
whole organism il6 expression increased amount, abnormal
|
tlx1cq201/cq201
|
chemical treatment by environment: lipopolysaccharide
|
Figure 1
from Xie et al., 2021
|
intestine il1b expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
liver nfkb2 expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
intestine il6 expression increased amount, abnormal
|
tlx1cq201/cq201
|
vaccine treatment: Aeromonas hydrophila
|
Figure 4
from Xie et al., 2021
|
whole organism tnfa expression increased amount, abnormal
|
tlx1cq201/cq201
|
chemical treatment by environment: lipopolysaccharide
|
Figure 1
from Xie et al., 2021
|
whole organism il1b expression increased amount, abnormal
|
tlx1cq201/cq201
|
bacterial treatment by exposure to environment: Aeromonas hydrophila
|
Figure 1
from Xie et al., 2021
|
kidney cpox expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney hbba1 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 1,
Fig. 5
from Xie et al., 2023
|
kidney cxcl18b expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 5
from Xie et al., 2023
|
kidney fech expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3,
Fig. 5
from Xie et al., 2023
|
kidney uros expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney tfr1a expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney gata1a expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 1,
Fig. 5
from Xie et al., 2023
|
kidney klf1 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 1,
Fig. 5
from Xie et al., 2023
|
kidney alas2 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney urod expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney steap3 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney abcb10 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney slc25a37 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney hbaa1 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 1,
Fig. 5
from Xie et al., 2023
|
kidney ppox expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney tfa expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney hbba2 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 1
from Xie et al., 2023
|
kidney hbaa2 expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 1
from Xie et al., 2023
|
kidney gata2a expression decreased amount, abnormal
|
tlx1cq201/cq201 (AB)
|
standard conditions
|
Fig. 1
from Xie et al., 2023
|
gut left side tlx1 expression absent, abnormal
|
tlx1cq202/cq202
|
standard conditions
|
Fig. 3
from Xie et al., 2019
|
whole organism decreased life span, exacerbated
|
tlx1cq202/cq202
|
bacterial treatment by injection: Aeromonas hydrophila
|
Fig. 5
from Xie et al., 2019
|
spleen absent, abnormal
|
tlx1cq202/cq202
|
standard conditions
|
Fig. 4
from Xie et al., 2019
|
kidney cpox expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney hbba1 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 1,
Fig. 5
from Xie et al., 2023
|
kidney cxcl18b expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 5
from Xie et al., 2023
|
kidney uros expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney fech expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3,
Fig. 5
from Xie et al., 2023
|
kidney tfr1a expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney gata1a expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 1,
Fig. 5
from Xie et al., 2023
|
kidney klf1 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 1,
Fig. 5
from Xie et al., 2023
|
kidney urod expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney alas2 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney steap3 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney abcb10 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney slc25a37 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney ppox expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney hbaa1 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 1,
Fig. 5
from Xie et al., 2023
|
kidney hbaa2 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 1
from Xie et al., 2023
|
kidney gata2a expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 1
from Xie et al., 2023
|
kidney tfa expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 3
from Xie et al., 2023
|
kidney hbba2 expression decreased amount, abnormal
|
tlx1cq202/cq202 (AB)
|
standard conditions
|
Fig. 1
from Xie et al., 2023
|